ELMO3 is a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.

Wei Fan(Huaian First People’s Hospital), Jun Zhang(Shihezi University), Haikou Yang(Shandong Maternal and Child Health Hospital), Yong Sun(Huaian First People’s Hospital), Hong Xue(Chengdu University)
PubMed
January 1, 2015
Cited by 18


Related Papers